Literature DB >> 11738245

Role of calcitonin gene-related peptide and its antagonist on the evoked discharge frequency of wide dynamic range neurons in the dorsal horn of the spinal cord in rats.

Yi Yu1, Thomas Lundeberg, Long Chuan Yu.   

Abstract

The present study was performed to explore the effect of calcitonin gene-related peptide (CGRP) and its antagonist CGRP8-37 on the evoked discharge frequency of wide dynamic range (WDR) neurons in the dorsal horn of the spinal cord in rats. Recording was performed with a multibarrelled glass micropipette and the chemicals were delivered by iontophoresis. The discharge of WDR neurons was evoked by transdermic electrical stimulation applied on the ipsilateral hindpaw. (1) Iontophoretic application of CGRP at an ejection current of 100 nA increased the discharge frequency of WDR neurons significantly. (2) Iontophoretic application of CGRP8-37 at an ejection current of 80 or 160 nA induced significant decreases in the discharge frequency of WDR neurons, but not at 40 nA. (3) Iontophoretic application of CGRP8-37 not only antagonized the CGRP-induced increase in the evoked discharge frequency of WDR neurons but also induced a significant decrease in the evoked discharge frequency of WDR neurons compared to basal levels. The results indicate that CGRP and its receptors play a facilitary role on the transmission and/or modulation of nociceptive information in the dorsal horn of the spinal cord in rats.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11738245     DOI: 10.1016/s0167-0115(01)00326-3

Source DB:  PubMed          Journal:  Regul Pept        ISSN: 0167-0115


  14 in total

1.  Spinal expression of Hippo signaling components YAP and TAZ following peripheral nerve injury in rats.

Authors:  Na Li; Grewo Lim; Lucy Chen; Michael F McCabe; Hyangin Kim; Shuzhuo Zhang; Jianren Mao
Journal:  Brain Res       Date:  2013-08-30       Impact factor: 3.252

Review 2.  Neuroplasticity of ascending and descending pathways after somatosensory system injury: reviewing knowledge to identify neuropathic pain therapeutic targets.

Authors:  P Boadas-Vaello; S Castany; J Homs; B Álvarez-Pérez; M Deulofeu; E Verdú
Journal:  Spinal Cord       Date:  2016-01-12       Impact factor: 2.772

Review 3.  CGRP receptor antagonism and migraine.

Authors:  Lars Edvinsson; Tony W Ho
Journal:  Neurotherapeutics       Date:  2010-04       Impact factor: 7.620

4.  Effect of CGRP and sumatriptan on the BOLD response in visual cortex.

Authors:  Mohammad S Asghar; Adam E Hansen; Henrik B W Larsson; Jes Olesen; Messoud Ashina
Journal:  J Headache Pain       Date:  2012-01-14       Impact factor: 7.277

Review 5.  The role of anti-CGRP antibodies in the pathophysiology of primary headaches.

Authors:  Piero Barbanti; Cinzia Aurilia; Luisa Fofi; Gabriella Egeo; Patrizia Ferroni
Journal:  Neurol Sci       Date:  2017-05       Impact factor: 3.307

6.  Exercise-induced gene expression changes in the rat spinal cord.

Authors:  Victoria M Perreau; Paul A Adlard; Aileen J Anderson; Carl W Cotman
Journal:  Gene Expr       Date:  2005

7.  Spinal CGRP1 receptors contribute to supraspinally organized pain behavior and pain-related sensitization of amygdala neurons.

Authors:  Hita Adwanikar; Guangchen Ji; Weidong Li; Henri Doods; William D Willis; Volker Neugebauer
Journal:  Pain       Date:  2007-03-01       Impact factor: 6.961

Review 8.  CGRP and its receptors provide new insights into migraine pathophysiology.

Authors:  Tony W Ho; Lars Edvinsson; Peter J Goadsby
Journal:  Nat Rev Neurol       Date:  2010-09-07       Impact factor: 42.937

9.  Neuropeptide Y inhibits capsaicin-sensitive nociceptors via a Y1-receptor-mediated mechanism.

Authors:  J Gibbs; C M Flores; K M Hargreaves
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

10.  Immobilization-induced hypersensitivity associated with spinal cord sensitization during cast immobilization and after cast removal in rats.

Authors:  Yohei Hamaue; Jiro Nakano; Yuki Sekino; Sayaka Chuganji; Jyunya Sakamoto; Toshiro Yoshimura; Tomoki Origuchi; Minoru Okita
Journal:  J Physiol Sci       Date:  2013-07-02       Impact factor: 2.781

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.